BlueWhale Bio is committed to advancing cell-based therapeutics through manufacturing innovation.
BlueWhale Bio has raised $5.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2025.
BlueWhale Bio's investors include Novalis LifeSciences, Marshall Wace, Danaher Ventures, Penn Medicine Co-Investment Program.
BlueWhale Bio is headquartered in Philadelphia, United States.
BlueWhale Bio is committed to advancing cell-based therapeutics through manufacturing innovation.
BlueWhale Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BlueWhale Bio — Funding & Investors." VCBacked, October 16, 2025, https://www.vcbacked.co/company/bluewhale-bio. Accessed August 15, 2026.
VCBacked. (2025). BlueWhale Bio — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/bluewhale-bio
{{cite web |title=BlueWhale Bio — Funding & Investors |url=https://www.vcbacked.co/company/bluewhale-bio |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated